Reliable Cancer Therapies Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Verbier Switzerland (2009)

Organization Overview

First Clinical Trial
2010
NCT01198821
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cancer Pain (Phase 1)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Endometrial Neoplasms (Phase 2)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Inflammation (Phase 2)

Lung Neoplasms (Phase 2)

Multiple Myeloma (Phase 1)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 1)

Osteosarcoma (Phase 1)

Pancreatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 19